MARC STEPHEN RASPANTI practices in the areas of Government Enforcement, Compliance, Internal Investigations, Federal and State White Collar Litigation; Federal and State Qui Tam Litigation; Criminal, Civil and Administrative Health Care Fraud Litigation; and Complex Commercial Litigation. Mr. Raspanti is the founder of the firm's national Qui Tam practice group and the firm's White Collar Criminal Defense practice group.

In March 1999, Philadelphia Magazine named Mr. Raspanti one of the best white collar criminal defense lawyers in Philadelphia. Following that honor, Mr. Raspanti was selected by his peers as a Pennsylvania Super Lawyers from 2004 through 2016 in the field of White Collar Criminal Defense. In addition, from 2007 through 2014, he was listed as one of the Top 100 Pennsylvania Super Lawyers. From 2008 through 2015, he was selected as one of the Top 100 Philadelphia Super Lawyers. He was also selected by his peers for the 2006 through 2017 editions of Best Lawyers in America in the area of Health Care Law litigation. Mr. Raspanti is also Chambers & Partners rated in the area of Healthcare. In November 2016, Mr. Raspanti was the recipient of the Twenty Second Annual Cesare Beccaria Award by the Justinian Society of Philadelphia and the Criminal Justice Section of the Philadelphia Bar Association.

In the area of White Collar Criminal Defense, Mr. Raspanti served as trial counsel in a number of complex, high-profile white collar criminal cases. In United States of America v. General Electric Company, he defended a former executive of the General Electric Company charged with criminal defense procurement fraud in a four-month jury trial. This case, which involved thousands of documents and hundreds of witnesses, was one of the longest and most complex white collar criminal trials ever tried in Pennsylvania. More recently, Mr. Raspanti successfully obtained an acquittal, after a lengthy federal jury trial, of a dermatologist charged with 79 counts of health care fraud related to dermatology procedures. He has represented numerous executives, corporations, physicians, health care providers, entrepreneurs, accountants, lawyers, politicians, and professionals in numerous federal and state investigations throughout the country.

In the area of Qui Tam litigation, Mr. Raspanti has litigated numerous high profile cases including; United States ex rel. Robert J. Merena v. SmithKline Beecham Clinical Laboratories, as well as co-lead counsel in United States ex rel. Bradford Hunt & Walter Gauger v. Merck-Medco Managed Care, LLC and in United States ex rel. James T. Monahan v. St. Barnabas Health System. Over the past 28 years, Mr. Raspanti has been involved in the recovery of over $2 billion for state and federal taxpayers.

In 2012, Mr. Raspanti was elected as a Fellow of the American College of Trial Lawyers, an organization devoted to recognizing outstanding civil and criminal trial lawyers in the United States and Canada. LexisNexis® Martindale-Hubbell® recognizes Mr. Raspanti as an AV® Preeminent™ rated attorney, the highest such rating available to any individual lawyer in both legal ability and ethical standards. Mr. Raspanti has a 10, superb, rating with AVVO, which evaluates attorney qualifications based on years in practice, professional achievements, and industry recognition.

Mr. Raspanti is a member of the Pennsylvania Association of Criminal Defense Lawyers (PACDL) and the National Association of Criminal Defense Lawyers (NACDL). He also serves on the Federal Bar Association’s Committee on Criminal Law as well as the Qui Tam Section and the Committee on Complex Criminal Litigation. Within the American Bar Association, Mr. Raspanti currently serves as the National Co-Chair of the Criminal Justice Section White Collar Sub-Committee on Qui Tam Litigation. Mr. Raspanti has been recognized as a national leader in his field by such organizations as Law Dragon 500 magazine and the US Healthcare Expert Guide. Mr. Raspanti is an active member of the Health Care Compliance Association as well as the American Health Lawyers Association.

While attending Temple University School of Law, Mr. Raspanti served as President of the Moot Court Board from 1983 to 1984. Mr. Raspanti is an ex officio member of the Board of Governors of the Justinian Society, having served as Secretary to the Society from 1998 to 2002. His past legal positions include Assistant District Attorney at the Philadelphia District Attorney's Office, where he tried a wide range of criminal cases to verdict, as well as several well-respected Philadelphia litigation firms.

From June 2007 through January 2010, Mr. Raspanti was appointed as a Commissioner by Governor Edward G. Rendell as the criminal defense representative to serve on the Pennsylvania Commission on Sentencing. The Commission creates a state-wide sentencing policy which promotes fair, consistent sentencing practices in order to provide judges with a common reference point for sentencing those convicted of felonies and misdemeanors. Mr. Raspanti was previously appointed to serve as a Commissioner on the Pennsylvania Commission on Crime and Delinquency.

On January 27, 2003, under recommendation from the Chief Justice of the Supreme Court of Pennsylvania appointed Mr. Raspanti to the Pennsylvania Disciplinary Board for a term of six years which concluded on January 27, 2009. He served as Chair of the Board’s education committee. Prior to his appointment to the 16-person Disciplinary Board, Mr. Raspanti served for six years as a Philadelphia Disciplinary Hearing Committee Member. He served as Chair of the 2016 Philadelphia Bar Association's Bench Bar Conference Committee.

Mr. Raspanti frequently speaks, writes, lectures and comments on white collar criminal defense, qui tam and health care fraud issues throughout the country. He served as an Adjunct Professor of Law at Hamline University School of Law in Minnesota where he taught classes in health care fraud, the False Claims Act, and pharmaceutical and medical device fraud. He speaks regularly at law schools and before professional trade organizations throughout the United States.